首页 | 本学科首页   官方微博 | 高级检索  
     


Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome
Authors:J. M. M. Van Lith  J. J. Pratt  J. R. Beekhuis  A. Mantingh
Affiliation:1. Deparlmenr of Clinical Biochemistry, University Hospital Groningen, Oostersingel 59, 9713 EZ Groningen. The Netherlands;2. Department of Obstetrics and Gynaecology, University Hospital Groningen. Oostersingel 59, 9713 EZ Groningen, The Netherlands
Abstract:We measured immunoreactive inhibin in the maternal serum of 80 pregnancies with a chromosomally normal fetus and ten Down's syndrome pregnancies in the second trimester. The inhibin level in all Down's syndrome pregnancies was above the normal median; the multiple of the normal median (MoM) was 1.9. We found a statistically significant difference between the levels of inhibin in unaffected and affected pregnancies (Kolmogorov–Smirnov test: p <0.002). Using an arbitrarily chosen cut-off of 2.4 MoM, 40 per cent of Down's syndrome and 5 per cent of the normal pregnancies were found. We conclude that immunoreactive inhibin may be useful as a marker for fetal Down's syndrome.
Keywords:Inhibin  Down's syndrome  Screening
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号